about
Analysis, physiological and clinical significance of 12-HETE: a neglected platelet-derived 12-lipoxygenase productNitric oxide synthetic pathway in patients with microvascular angina and its relations with oxidative stressApocynin prevents cyclooxygenase 2 expression in human monocytes through NADPH oxidase and glutathione redox-dependent mechanisms.Circulating levels of dimethylarginines, chronic kidney disease and long-term clinical outcome in non-ST-elevation myocardial infarction.Nitric oxide synthetic pathway in red blood cells is impaired in coronary artery disease.8-Hydroxy-2-Deoxyguanosine Levels and Cardiovascular Disease: A Systematic Review and Meta-Analysis of the LiteratureOxidative stress and nitric oxide pathway in adult patients who are candidates for cardiac surgery: patterns and differences.The red blood cell: a new key player in cardiovascular homoeostasis? Focus on the nitric oxide pathway.8-Hydroxy-2-deoxyguanosine levels and heart failure: A systematic review and meta-analysis of the literature.OXY-SCORE: a global index to improve evaluation of oxidative stress by combining pro- and antioxidant markers.Assessment of oxidative stress in coronary artery bypass surgery: comparison between the global index OXY-SCORE and individual biomarkers.Simultaneous quantification of 8-iso-prostaglandin-F(2alpha) and 11-dehydro thromboxane B(2) in human urine by liquid chromatography-tandem mass spectrometry.The aminotetraline derivative (+/-)-(R,S)-5,6-dihydroxy-2-methylamino-1,2,3,4-tetrahydro-naphthalene hydrochloride (CHF-1024) displays cardioprotection in postischemic ventricular dysfunction of the rat heart.Neurohormonal activation is associated with increased levels of plasma matrix metalloproteinase-2 in human heart failure.Diversity and similarity in signaling events leading to rapid Cox-2 induction by tumor necrosis factor-alpha and phorbol ester in human endothelial cells.Effects of smoking regular or light cigarettes on brachial artery flow-mediated dilation.Glutathione, vitamin E and oxidative stress in coronary artery disease: relevance of age and gender.Surface-activated chemical ionization in the analysis of arginine in plasma samples.Anesthetic propofol enhances plasma gamma-tocopherol levels in patients undergoing cardiac surgery.Isoprostanes and oxidative stress in off-pump and on-pump coronary bypass surgery.In Vivo Platelet Activation and Aspirin Responsiveness in Type 1 Diabetes.In vivo prostacyclin biosynthesis and effects of different aspirin regimens in patients with essential thrombocythaemia.Genotype-independent in vivo oxidative stress following a methionine loading test: maximal platelet activation in subjects with early-onset thrombosis.Urinary excretion of iPF(2α)-III predicts the risk of future thrombotic events. A 10-year follow-up.Cytoskeletal architecture regulates cyclooxygenase-2 in human endothelial cells: autocrine modulation by prostacyclin.Direct glutathione quantification in human blood by LC-MS/MS: comparison with HPLC with electrochemical detection.Patient-independent variables affecting the assessment of aspirin responsiveness by serum thromboxane measurement.Role of thromboxane-dependent platelet activation in venous thrombosis: Aspirin effects in mouse model.Liquid chromatography–tandem mass spectrometry for simultaneous measurement of thromboxane B2 and 12(S)-hydroxyeicosatetraenoic acid in serumQuantification of arginine and its metabolites in human erythrocytes using liquid chromatography–tandem mass spectrometryA new compound-specific pleiotropic effect of statins: Modification of plasma gamma-tocopherol levelsAge- and gender-related oxidative status determined in healthy subjects by means of OXY-SCORE, a potential new comprehensive index
P50
Q28237168-33D51EAE-6B84-4905-ABD6-C3EDB800FF0BQ33594387-F7AADDC8-77A5-4EED-BF70-57729599EAFBQ34327555-ACE14CFF-F81D-4A31-8C0C-FC36F90215C8Q34489684-5142DAD9-14AC-48B1-83E2-1BDB6B35AA40Q34934327-918DED0A-8E71-4249-A79E-0A7CD8C76352Q36786199-ECEFCED5-D4E8-4CFA-8D63-C97E525977E9Q37312430-404B7EA5-0507-477D-832F-E5839ED3AA13Q38238643-F5A620AD-F19E-49B6-AD5B-7E37333E3440Q39074751-6E70640F-C575-4F47-B212-B2E12DAA85D2Q43194921-FA3ACB30-D18C-45A5-8CB8-BD56503138A7Q43253512-D4045234-1A30-4EED-944F-58B6715A8124Q43262405-753F959B-48AC-4B98-93CA-C63FEA862EDAQ44585547-065B2AE0-B360-4DF3-8DBE-444D0470DDB7Q45200505-0ECA384D-EA8A-4FA6-AFD1-0B86A73B1874Q45233761-B3B3AD3A-0186-4766-A32C-3F4DB23962C4Q45329911-69527E07-93B8-4FF3-85CF-D7FDD3E161D3Q46085361-D9D02C0C-EB1A-4495-84FB-EB04F4C598C2Q46444577-AAE297D0-9DA7-4ECD-83A6-477B8DA63805Q46581045-3D95FF2B-F77D-4FE2-A69E-E51B995B2F2EQ46904924-EE9484FB-6847-4200-BBD7-08AD4D9DFA8AQ48119354-14FDD2DD-F6A3-4749-B2C6-1AE401814A35Q51287516-B6A9684C-5873-4F80-9B59-32D1E2D1E328Q51372130-93EAF9B5-718A-49FC-8AEC-C00CABCA5774Q51665856-09FF28B1-F6BA-4C77-8558-4EA77FCEA01CQ52624182-3469DE8D-2E43-44F7-8874-80EC24BA5F08Q53105356-DC806031-3C1B-4F63-B15C-CACB95898FADQ53213155-A6EBAF9A-5479-4E09-B938-EF0A13D5DD02Q54583671-CFCEAAB8-E38E-4D20-914E-E52D0873F0EDQ57398722-3DFB5B81-641F-4D97-9F92-15D3799FF2A8Q57398736-FB1F5B4A-EC7E-4AD5-9A53-6AF22314D225Q57398789-6DA790F3-66BD-499F-84DF-1DF1F86C54FFQ57398825-BB0846CE-D2FC-4BDB-9AD0-B66E631EFAD6
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Viviana Cavalca
@ast
Viviana Cavalca
@en
Viviana Cavalca
@es
Viviana Cavalca
@nl
Viviana Cavalca
@sl
type
label
Viviana Cavalca
@ast
Viviana Cavalca
@en
Viviana Cavalca
@es
Viviana Cavalca
@nl
Viviana Cavalca
@sl
prefLabel
Viviana Cavalca
@ast
Viviana Cavalca
@en
Viviana Cavalca
@es
Viviana Cavalca
@nl
Viviana Cavalca
@sl
P106
P1153
6602678306
P21
P31
P496
0000-0003-1349-8365